Biomarkers for Sleep Apnea

Abstract

Obstructive sleep apnea (OSA) is a substantial medical problem with significant morbidity, both in the pediatric population and in adults. The gold standard for diagnosis and assessment of response to treatment has been overnight polysomnography. However, it is costly, time-consuming, and inconvenient to the patients. Thus, there is an emerging need for markers that would identify patients with OSA, especially those at risk for complications who require closer surveillance and more aggressive treatment. In recent years, a large number of studies have been conducted to search for the ideal biomarker in the blood and other body fluids, mainly urine, saliva, and exhaled breath. We present a literature review of current literature on biomarkers of OSA. We conclude that the ideal sole biomarker has not been found yet, but several markers have the potential to serve as screening tools; an array of markers, as well as analysis of epigenetic factors, could serve in diagnosis and in tailoring the best specific treatment for the single patient.

Keywords

biomarkers - sleep apnea - polysomnography

^* These authors contributed equally to this study.

• References

• 1 Montesi SB, Bajwa EK, Malhotra A. Biomarkers of sleep apnea. Chest 2012; 142 (1) 239-245
• 2 Gozal D, Jortani S, Snow AB , et al. Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 2009; 180 (12) 1253-1261
• 3 De Luca Canto G, Pachêco-Pereira C, Aydinoz S, Major PW, Flores-Mir C, Gozal D. Biomarkers associated with obstructive sleep apnea and morbidities: a scoping review. Sleep Med 2015; 16 (3) 347-357
• 4 Rosen CL, Larkin EK, Kirchner HL , et al. Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity. J Pediatr 2003; 142 (4) 383-389
• 5 Kapur VK. Obstructive sleep apnea: diagnosis, epidemiology, and economics. Respir Care 2010; 55 (9) 1155-1167
• 6 Kheirandish-Gozal L. What is “abnormal” in pediatric sleep?. Respir Care 2010; 55 (10) 1366-1374 , discussion 1374–1376
• 7 Castell JV, Gómez-Lechón MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12 (5) 1179-1186
• 8 Gozal D, Crabtree VM, Sans Capdevila O, Witcher LA, Kheirandish-Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med 2007; 176 (2) 188-193
• 9 Kritikou I, Basta M, Vgontzas AN , et al. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Respir J 2014; 43 (1) 145-155
• 10 Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006; 174 (7) 824-830
• 11 Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000; 148 (2) 209-214
• 12 Guilleminault C, Kirisoglu C, Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep 2004; 27 (8) 1507-1511
• 13 Riha RL, Brander P, Vennelle M , et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 2005; 26 (4) 673-678
• 14 Bhushan B, Guleria R, Misra A, Luthra K, Vikram NK. TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med 2009; 103 (3) 386-392
• 15 Nadeem R, Molnar J, Madbouly EM , et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013; 9 (10) 1003-1012
• 16 Fornadi K, Lindner A, Czira ME , et al. Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients. Int Urol Nephrol 2012; 44 (2) 607-617
• 17 Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 2011; 6 (3) 120-125
• 18 Chin K, Ohi M, Kita H , et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996; 153 (6 Pt 1): 1972-1976
• 19 Shamsuzzaman A, Amin RS, Calvin AD, Davison D, Somers VK. Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients. Sleep Breath 2014; 18 (4) 761-766
• 20 Kaditis AG, Alexopoulos EI, Kalampouka E , et al. Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J 2004; 24 (5) 790-797
• 21 Phillips CL, McEwen BJ, Morel-Kopp M-C , et al. Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax 2012; 67 (7) 639-644
• 22 Steiropoulos P, Papanas N, Nena E , et al. Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?. Mediators Inflamm 2010; 2010: 675320 . Doi: 10.1155/2010/675320
• 23 Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2010; 28 (1) 157-183
• 24 Ciccone MM, Scicchitano P, Zito A , et al. Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules 2014; 19 (2) 1651-1662
• 25 Kobukai Y, Koyama T, Watanabe H, Ito H. Morning pentraxin 3 levels reflect obstructive sleep apnea-related acute inflammation. J Appl Physiol (1985) 2014; 117 (10) 1141-1148
• 26 Yasunaga T, Ikeda S, Koga S , et al. Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein. Int Heart J 2014; 55 (2) 160-164
• 27 Shen P, Han Y, Cai B, Wang Y. Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome. Sleep Breath 2015; 19 (2) 515-522
• 28 Ichimura A, Hirasawa A, Poulain-Godefroy O , et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 2012; 483 (7389): 350-354
• 29 Oh DY, Talukdar S, Bae EJ , et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142 (5) 687-698
• 30 Gozal D, Kheirandish-Gozal L, Carreras A, Khalyfa A, Peris E. Obstructive sleep apnea and obesity are associated with reduced GPR 120 plasma levels in children. Sleep 2014; 37 (5) 935-941
• 31 Li W, Yu Z, Jiang C. Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome. Lab Med 2014; 45 (3) 220-225
• 32 Wang X, Xing G-H. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome. Scand J Clin Lab Invest 2014; 74 (1) 74-78
• 33 Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol 2015; 4: 180-183
• 34 Liu H-G, Liu K, Zhou Y-N, Xu Y-J. Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population. Chin Med J (Engl) 2009; 122 (12) 1369-1374
• 35 Schulz R, Schmidt D, Blum A , et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55 (12) 1046-1051
• 36 Wysocka E, Cofta S, Cymerys M, Gozdzik J, Torlinski L, Batura-Gabryel H. The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients. J Physiol Pharmacol 2008; 59 (Suppl 6): 761-769
• 37 Alonso-Fernández A, García-Río F, Arias MA , et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009; 64 (7) 581-586
• 38 Findley LJ, Boykin M, Fallon T, Belardinelli L. Plasma adenosine and hypoxemia in patients with sleep apnea. J Appl Physiol (1985) 1988; 64 (2) 556-561
• 39 Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987; 10 (1) 35-44
• 40 Paci A, Marrone O, Lenzi S , et al. Endogenous digitalislike factors in obstructive sleep apnea. Hypertens Res 2000; 23 (Suppl): S87-S91
• 41 Lin SW, Tsai CN, Lee YS, Chu SF, Chen NH. Gene expression profiles in peripheral blood mononuclear cells of Asian obstructive sleep apnea patients. Biomed J 2014; 37 (2) 60-70
• 42 Kim J, Bhattacharjee R, Khalyfa A , et al. DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med 2012; 185 (3) 330-338
• 43 Kheirandish-Gozal L, Khalyfa A, Gozal D, Bhattacharjee R, Wang Y. Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene. Chest 2013; 143 (4) 971-977
• 44 Khalyfa A, Bhushan B, Hegazi M , et al. Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels. Lipids Health Dis 2010; 9 (1) 18 . Doi: 10.1186/1476-511X-9-18
• 45 Bhushan B, Khalyfa A, Spruyt K , et al. Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med 2011; 12 (7) 666-671
• 46 Khalyfa A, Kheirandish-Gozal L, Capdevila OS, Bhattacharjee R, Gozal D. Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea. Pediatr Pulmonol 2012; 47 (10) 1001-1011
• 47 Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010; 181 (5) 507-513
• 48 Papanas N, Steiropoulos P, Nena E , et al. HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag 2009; 5: 751-756
• 49 Gozal D, Sans Capdevila O, McLaughlin Crabtree V, Serpero LD, Witcher LA, Kheirandish-Gozal L. Plasma IGF-1 levels and cognitive dysfunction in children with obstructive sleep apnea. Sleep Med 2009; 10 (2) 167-173
• 50 Shah ZA, Jortani SA, Tauman R, Valdes Jr R, Gozal D. Serum proteomic patterns associated with sleep-disordered breathing in children. Pediatr Res 2006; 59 (3) 466-470
• 51 De Luca Canto G, Pachêco-Pereira C, Aydinoz S, Major PW, Flores-Mir C, Gozal D. Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 2015; 11 (1) 27-36
• 52 Nelson DH, Sandberg AA, Palmer JG, Tyler FH. Blood levels of 17-hydroxycorticosteroids following the administration of adrenal steroids and their relation to levels of circulating leukocytes. J Clin Invest 1952; 31 (9) 843-849
• 53 Thomson SP, McMahon LJ, Nugent CA. Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin Immunol Immunopathol 1980; 17 (4) 506-514
• 54 Koseoglu HI, Altunkas F, Kanbay A, Doruk S, Etikan I, Demir O. Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. J Thromb Thrombolysis 2015; 39 (2) 179-185
• 55 Kheirandish-Gozal L, Peris E, Gozal D. Vitamin D levels and obstructive sleep apnoea in children. Sleep Med 2014; 15 (4) 459-463
• 56 Villa MP, Supino MC, Fedeli S , et al. Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS. Sleep Breath 2014; 18 (4) 723-729
• 57 Montgomery-Downs HE, Krishna J, Roberts II LJ, Gozal D. Urinary F2-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep Breath 2006; 10 (4) 211-215
• 58 Monneret D, Pepin J-L, Godin-Ribuot D , et al. Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients. Free Radic Biol Med 2010; 48 (4) 619-625
• 59 Del Ben M, Fabiani M, Loffredo L , et al. Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm Med 2012; 12 (1) 36 . Doi: 10.1186/1471-2466-12-36
• 60 Stanke-Labesque F, Bäck M, Lefebvre B , et al. Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia. J Allergy Clin Immunol 2009; 124 (2) 364-370 , 370.e1–370.e2
• 61 Kaditis AG, Alexopoulos E, Chaidas K , et al. Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest 2009; 135 (6) 1496-1501
• 62 Arias MA, García-Río F, Alonso-Fernández A , et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008; 32 (4) 1009-1015
• 63 O'Driscoll DM, Horne RSC, Davey MJ , et al. Increased sympathetic activity in children with obstructive sleep apnea: cardiovascular implications. Sleep Med 2011; 12 (5) 483-488
• 64 Kaditis AG, Alexopoulos EI, Damani E , et al. Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol 2009; 44 (1) 38-45
• 65 Kelly A, Dougherty S, Cucchiara A, Marcus CL, Brooks LJ. Catecholamines, adiponectin, and insulin resistance as measured by HOMA in children with obstructive sleep apnea. Sleep 2010; 33 (9) 1185-1191
• 66 Kheirandish-Gozal L, McManus CJT, Kellermann GH, Samiei A, Gozal D. Urinary neurotransmitters are selectively altered in children with obstructive sleep apnea and predict cognitive morbidity. Chest 2013; 143 (6) 1576-1583
• 67 Lam JCM, Yan CSW, Lai AYK , et al. Determinants of daytime blood pressure in relation to obstructive sleep apnea in men. Lung 2009; 187 (5) 291-298
• 68 Pinto P, Bárbara C, Montserrat JM , et al. Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea. BMC Pulm Med 2013; 13 (13) 13 . Doi: 10.1186/1471-2466-13-13
• 69 Sukegawa M, Noda A, Sugiura T , et al. Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines. Clin Cardiol 2005; 28 (11) 519-522
• 70 Minemura H, Akashiba T, Yamamoto H, Akahoshi T, Kosaka N, Horie T. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea. Intern Med 1998; 37 (12) 1009-1013
• 71 Phillips CL, Yang Q, Williams A , et al. The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res 2007; 16 (12) 217-225
• 72 Kohler M, Stoewhas A-C, Ayers L , et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2011; 184 (10) 1192-1199
• 73 Krishna J, Shah ZA, Merchant M, Klein JB, Gozal D. Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med 2006; 7 (3) 221-227
• 74 Monneret D, Tamisier R, Ducros V , et al. The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome. Respir Physiol Neurobiol 2012; 180 (02/03) 298-304
• 75 Park CS, Guilleminault C, Hwang SH, Jeong JH, Park DS, Maeng JH. Correlation of salivary cortisol level with obstructive sleep apnea syndrome in pediatric subjects. Sleep Med 2013; 14 (10) 978-984
• 76 Jeong J-H, Guilleminault C, Park C-S , et al. Changes in salivary cortisol levels in pediatric patients with obstructive sleep apnea syndrome after adenotonsillectomy. Sleep Med 2014; 15 (6) 672-676
• 77 Patacchioli FR, Tabarrini A, Ghiciuc CM , et al. Salivary biomarkers of obstructive sleep apnea syndrome in children. Pediatr Pulmonol 2014; 49 (11) 1145-1152
• 78 Park CS, Guilleminault C, Park HJ , et al. Correlation of salivary alpha amylase level and adenotonsillar hypertrophy with sleep disordered breathing in pediatric subjects. J Clin Sleep Med 2014; 10 (5) 559-566
• 79 Celec P, Hodosy J, Behuliak M , et al. Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 2012; 16 (2) 393-398
• 80 Papaioannou I, Twigg GL, Kemp M , et al. Melatonin concentration as a marker of the circadian phase in patients with obstructive sleep apnoea. Sleep Med 2012; 13 (2) 167-171
• 81 Malakasioti G, Alexopoulos E, Befani C , et al. Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA. Sleep Breath 2012; 16 (3) 703-708
• 82 Bikov A, Hull JH, Kunos L. Exhaled breath analysis, a simple tool to study the pathophysiology of obstructive sleep apnoea. Sleep Med Rev 2016; 27: 1-8
• 83 Biltagi MA, Maguid MA, Ghafar MA, Farid E. Correlation of 8-isoprostane, interleukin-6 and cardiac functions with clinical score in childhood obstructive sleep apnoea. Acta Paediatr 2008; 97 (10) 1397-1405
• 84 Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003; 124 (4) 1386-1392
• 85 Petrosyan M, Perraki E, Simoes D , et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath 2008; 12 (3) 207-215
• 86 Antonopoulou S, Loukides S, Papatheodorou G, Roussos C, Alchanatis M. Airway inflammation in obstructive sleep apnea: is leptin the missing link?. Respir Med 2008; 102 (10) 1399-1405
• 87 Li Y, Chongsuvivatwong V, Geater A, Liu A. Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med 2009; 10 (1) 95-103
• 88 Vlasic V, Trifunovic J, Cepelak I, Nimac P, Topic RZ, Dodig S. Urates in exhaled breath condensate of children with obstructive sleep apnea. Biochem Med (Zagreb) 2011; 21 (2) 139-144
• 89 Goldbart AD, Krishna J, Li RC, Serpero LD, Gozal D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006; 130 (1) 143-148
• 90 Aihara K, Oga T, Chihara Y , et al. Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep Breath 2013; 17 (2) 597-604
• 91 Benedek P, Lázár Z, Bikov A, Kunos L, Katona G, Horváth I. Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome. Int J Pediatr Otorhinolaryngol 2013; 77 (8) 1244-1247
• 92 Bayrakli I, OztUrk O, Akman H. Investigation of acetone, butanol and carbon dioxide as new breath biomarkers for convenient and noninvasive diagnosis of obstructive sleep apnea syndrome. Biomed Chromatogr 2016;
• 93 Culla B, Guida G, Brussino L , et al. Increased oral nitric oxide in obstructive sleep apnoea. Respir Med 2010; 104 (2) 316-320
• 94 Gut G, Tauman R, Greenfeld M, Armoni-Domany K, Sivan Y. Nasal nitric oxide in sleep-disordered breathing in children. Sleep Breath 2016; 20 (1) 303-308